Results 31 to 40 of about 3,238 (182)

Radical Irradiation of Extracranial Oligometastases [PDF]

Journal of Clinical Oncology, 2014
Advances in radiotherapy planning and delivery have been used to treat patients with limited metastatic disease. With these techniques, high rates of treated metastasis control and low toxicity have been reported. Some patients have long disease-free intervals after radiotherapy similar to those seen after surgical resection.
Joseph K, Salama, Michael T, Milano
openaire   +2 more sources

Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study

BMC Cancer, 2019
Background It was reported that tumor-expressed dickkopf-related (DKK) proteins affect micro-environment. However, the influence of DKK1 on colorectal cancer (CRC) liver oligometastases (CRCLOM) remains unclear. Methods CRC cases after resection of liver
Qiaoqi Sui, Jian Zheng, Dingxin Liu, Jianhong Peng, Qingjian Ou, Jinghua Tang, Yuan Li, Lingheng Kong, Wu Jiang, Binyi Xiao, Xue Chao, Zhizhong Pan, Huizhong Zhang, Pei-Rong Ding   +13 more
doaj   +1 more source

Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience

Frontiers in Oncology, 2018
Hypo-fractionated radiotherapy and stereotactic body radiotherapy are viable options for treatment of oligometastases. A prodrug of mitomycin-C is under clinical testing as a pegylated liposomal formulation (Promitil) with an improved safety profile over
Esther Tahover, Rachel Bar-Shalom, Eli Sapir, Raphael Pfeffer, Igor Nemirovsky, Yehonatan Turner, Maya Gips, Patricia Ohana, Benjamin W. Corn, Andrew Z. Wang, Alberto A. Gabizon, Alberto A. Gabizon, Alberto A. Gabizon   +12 more
doaj   +1 more source

Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression

Diagnostics, 2023
Stereotactic ablative radiotherapy (SABR) may improve survival in patients with inoperable pulmonary oligometastases. However, the impact of pulmonary oligometastatic status after systemic therapy on SABR outcomes remains unclear.
Chin-Beng Ho, Jo-Ting Tsai, Chun-You Chen, Her-Shyong Shiah, Hsuan-Yu Chen, Lai-Lei Ting, Chia-Chun Kuo, I-Chun Lai, Hsin-Yi Lai, Chi-Li Chung, Kai-Ling Lee, Huey-En Tzeng, Kuen-Haur Lee, Hsin-Lun Lee, Shang-Wen Chen, Jeng-Fong Chiou   +15 more
doaj   +1 more source

Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients

Frontiers in Oncology, 2021
AimsTo evaluate the efficacy and toxicity of extracranial stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic lymph node involvement in the mediastinum, retroperitoneum, or pelvis, in a consecutive group of patients from real ...
Petr Burkon, Petr Burkon, Iveta Selingerova, Marek Slavik, Marek Slavik, Petr Pospisil, Petr Pospisil, Lukas Bobek, Libor Kominek, Pavel Osmera, Tomas Prochazka, Tomas Prochazka, Miroslav Vrzal, Tomas Kazda, Tomas Kazda, Tomas Kazda, Pavel Slampa, Pavel Slampa   +17 more
doaj   +1 more source

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer

Pulmonary Medicine, 2012
Purpose. To retrospectively evaluate the clinical significance of radiotherapy for oligometastases of bone in prostate cancer (PCa). Methods and Materials.
Ken-ichi Tabata, Yuzuru Niibe, Takefumi Satoh, Hideyasu Tsumura, Masaomi Ikeda, Satoru Minamida, Tetsuo Fujita, Daisuke Ishii, Masatsugu Iwamura, Kazushige Hayakawa, Shiro Baba   +10 more
doaj   +1 more source

Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature

Future Science OA, 2020
It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy (SBRT) for lung oligometastases. A systematic review of literature with a priori selection criteria was conducted on articles on the treatment of pulmonary ...
Francesco Londero, William Grossi, Angelo Morelli, Orlando Parise, Gianluca Masullo, Cecilia Tetta, Ugolino Livi, Jos G Maessen, Sandro Gelsomino   +8 more
doaj   +1 more source

Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)

Frontiers in Oncology, 2022
Treatment of a limited number of brain metastases (oligometastases) might include complex and sometimes invasive approaches, e.g. neurosurgical resection followed by post-operative stereotactic radiotherapy, and thus, correct identification of patients ...
Carsten Nieder, Carsten Nieder, Nicolaus H. Andratschke, Anca L. Grosu   +3 more
doaj   +1 more source

Highlights on the Management of Oligometastatic Disease [PDF]

Journal of Immunotherapy and Precision Oncology, 2020
Purpose: The understanding of oligometastatic disease (OMD) is rapidly evolving and with this comes the ability to utilize a number of modalities that excel in the localized control of disease.
Salem M. Alshehri, Khaled Alkattan, Ahmed Abdelwarith, Hussain Alhussain, Shaker Shaker, Majed Alghamdi, Hossam Alassaf, Ali Albargawi, Manal Al Naimi, Ameen Alomair, Saif Althaqfi, Adnan Alhebshi, Majid Alothman, AbdulRahman Jazieh   +13 more
doaj   +1 more source

Stereotactic body radiotherapy for oligometastases

The Lancet Oncology, 2013
The management of metastatic solid tumours has historically focused on systemic treatment given with palliative intent. However, radical surgical treatment of oligometastases is now common practice in some settings. The development of stereotactic body radiotherapy (SBRT), building on improvements in delivery achieved by intensity-modulated and image ...
Tree, A, Khoo, V, Eeles, R, Ahmed, M, Dearnaley, D, Hawkins, M, Huddart, R, Nutting, C, Ostler, P, van As, N   +9 more
openaire   +3 more sources